AbioMed

From Self-sufficiency
Revision as of 00:47, 25 July 2010 by Jfdwolff (Talk) (rv - this reads like a brochure)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Abiomed Inc.
Industry Medical Devices
Founded 1981
Headquarters Danvers, MA United States and Aachen, Germany
Key people Michael R. Minogue, CEO, President & Chairman of the board
Mr. Robert L. Bowen, CFO
Dr. David Weber, COO
Products AbioCor
Impella
iPulse
IAB
AB5000
BVS 5000
Revenue 11px US$73.2 Million (FY 2009)[1]
Operating income US$-29.5 Million (FY 2009)[1]
Net income US$-31.6 Million (FY 2009)[1]
Total assets 11px US$136 Million (FY 2009)[2]
Total equity 11px US$116 Million (FY 2009)[2]
Employees 300+ (end of 2008)
Website www.abiomed.com

ABIOMED is a company based in Danvers, Massachusetts which builds the AbioCor Artificial Heart, the first fully implanted device of its kind.

Abiomed was founded in 1981 and is the only company in the world with exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The Company develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. Abiomed is the global leader for products in the acute heart failure market and ships more ventricle assist devices (VADs) than any other company in the world.[citation needed]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links


es:Abiomed
  1. 1.0 1.1 1.2 ABIOMED (ABMD) annual SEC income statement filing via Wikinvest
  2. 2.0 2.1 ABIOMED (ABMD) annual SEC balance sheet filing via Wikinvest